Showing results (101-110 of 7,823) with videos related to
Sort By:
Pageof 783
Psychosomatic Medicine|March 1, 1976
Intravenous l-DOPA plus carbidopa in depressed patients: average evoked response, learning, and behavioral changesG M Henry, M Buchsbaum, D L MurphyPsychiatry Research|June 1, 1992
Obsessive-compulsive characteristics in patients with idiopathic spasmodic torticollisK Bihari, J L Hill, D L MurphyThe Psychiatric Clinics of North America|September 1, 1984
Monoamine oxidase-inhibiting antidepressants. A clinical updateD L Murphy, T Sunderland, R M CohenBritish Journal of Pharmacology|October 1, 1977
Evaluation of the uptake of various amines into storage vesicles of intact human plateletsJ L Costa, D L Murphy, J ReveillePsychological Medicine|November 1, 1983
Parents of patients with obsessive-compulsive disorderT R Insel, C Hoover, D L MurphyPsychosomatic Medicine|March 1, 1979
Platelet monoamine oxidase activity correlates with social affiliative and agonistic behaviors in normal rhesus monkeysD E Redmond, D L Murphy, J BauluPsychopharmacology|September 1, 1996
Daily administration of m-chlorophenylpiperazine to healthy human volunteers rapidly attenuates many of its behavioral, hormonal, cardiovascular and temperature effectsJ Benjamin, B D Greenberg, D L MurphyBehavioural Brain Research|February 20, 2007
What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depressionA V Kalueff, M Wheaton, D L MurphyProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
Hyperlocomotion induced by dopamine or cholecystokinin + dopamine in the nucleus accumbens is not modified by chronic lithium treatmentJ Zohar, D L Murphy, J N CrawleyPsychopharmacology|January 1, 1986
Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humansE A Mueller, D L Murphy, T SunderlandPageof 783